GlassScriptPhysician profile
Alan Y Tsai
NPI 1154841682
$4,946.31
in general payments reported to CMS, 2019-2025
29 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $369 · 2021: $424 · 2022: $705 · 2023: $633 · 2024: $949 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,823.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $799.22 | 2019-2025 | Cequa |
| Alcon Vision LLC | $705.17 | 2019-2025 | Tryptyr, Precision7, Rocklatan |
| Allergan, INC. | $568.06 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $517.70 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $478.77 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $278.45 | 2022-2025 | Miebo, Xiidra, Infuse |
| Samsara Vision | $205.88 | 2023-2024 | |
| Glaukos Corporation | $201.49 | 2021-2025 | Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $178.71 | 2020-2025 | Catalys System, Tecnis Iol, Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $153.11 | 2019-2021 | |
| Harrow Eye, LLC | $152.73 | 2024-2025 | Vevye, Iheezo |
| Coopervision INC. | $120.72 | 2019-2023 | Myday Contact Lens |
| Integra Lifesciences Corporation | $107.06 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sight Sciences, INC. | $83.82 | 2022-2023 | Omni Surgical System |
| Kala Pharmaceuticals, INC. | $76.74 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $63.42 | 2021-2024 | Acthar |
| Mallinckrodt Enterprises LLC | $44.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.76 | 2021-2023 | |
| Menicon America INC | $28.30 | 2019 | |
| Linvatec Corporation | $23.62 | 2019 | |
| Dompe US, INC. | $18.98 | 2025 | Oxervate |
| Amgen INC. | $17.78 | 2024 | Tepezza |
| Ani Pharmaceuticals, INC. | $15.65 | 2025 | Purified Cortrophin Gel |
| Shire North American Group INC | $14.81 | 2019 | |
| Thea Pharma INC. | $13.22 | 2024 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $13.06 | 2021 | |
| Eyevance Pharmaceuticals LLC | $12.23 | 2020 | |
| Abbvie INC. | $11.64 | 2022 | |
| Merz Pharmaceuticals, LLC | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.